SCHEMBL7915840

SCHEMBL7915840

CN(C)c1cccc(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
MAPT P10636 3/20 0.53
MAPK1 P28482 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
NSD2 O96028 1/20 0.53
EGFR P00533 1/20 0.53
LMNA P02545 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
PDK2 Q15119 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PGR P06401 1/20 0.38
HTR7 P34969 3/20 0.38
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
HNF4A P41235 1/20 0.37
HSD17B10 Q99714 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL28055010 0.96 ALDH1A1 (0.50) ALDH1A1MAPTMAPK1L3MBTL1NSD2
SCHEMBL6724502 0.88 ALDH1A1 (0.40) ALDH1A1MAPTMAPK1L3MBTL1NSD2
SCHEMBL28285937 0.87 MAPT (0.50) ALDH1A1MAPTMAPK1L3MBTL1NSD2
SCHEMBL29433183 0.82 ALDH1A1 (0.45) ALDH1A1MAPTMAPK1L3MBTL1NSD2
SCHEMBL1254512 0.82 ALDH1A1 (0.45) ALDH1A1MAPTMAPK1L3MBTL1NSD2
SCHEMBL30763243 0.80 ALDH1A1 (0.44) ALDH1A1MAPTMAPK1L3MBTL1NSD2
SCHEMBL27516508 0.80 ALDH1A1 (0.44) ALDH1A1MAPTMAPK1L3MBTL1NSD2
Hydrochloric Acid SCHEMBL2866856 0.80 ALDH1A1 (0.44) ALDH1A1MAPTMAPK1L3MBTL1NSD2
SCHEMBL27517786 0.80 ALDH1A1 (0.44) ALDH1A1MAPTMAPK1L3MBTL1NSD2
SCHEMBL20955314 0.80 ALDH1A1 (0.39) ALDH1A1MAPTMAPK1L3MBTL1NSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180066000-A1 Metal Complexes and Electroluminescent Devices Comprising These Metal Complexes MERCK PATENT GMBH (DE) 2018-03-08 US disclosed
US-6208074-B1 Double-sided electroluminescent device DPR-ECUBLENS (CH) 2001-03-27 US disclosed
EP-0891686-B1 ELECTROLUMINESCENT DEVICE ECOLE POLYTECH (CH) 1999-10-06 EP disclosed
EP-0891686-A1 ELECTROLUMINESCENT DEVICE Ecole Polytechnique Féderale de Lausanne (EPFL) (CH) 1999-01-20 EP disclosed
WO-1997038558-A1 ELECTROLUMINESCENT DEVICE ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) 1997-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180066000-A1 Metal Complexes and Electroluminescent Devices Comprising These Metal Complexes OCIAD2, OCIAD1, ICOSLG ALDH1A1 1459/4885MAPT 1029/4885MAPK1 3051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.